|
Characteristic
|
Control (n = 16)
|
Aerobic (n = 15)
|
Resistance (n = 16)
|
Combination (n = 17)
|
|---|
|
Male/Female
|
1/15
|
3/12
|
3/13
|
3/14
|
|
Age (years)
|
52 ± 1.8
|
55 ± 1.2
|
52 ± 1.1
|
53 ± 1.3
|
| |
(40 – 66)
|
(44 – 62)
|
(43 – 59)
|
(43 – 64)
|
|
Weight (kg)
|
85.1 ± 4.2
|
91.9 ± 4.1
|
89.3 ± 4.5
|
90 ± 4
|
| |
(64.8 – 123)
|
(65.9 – 124.1)
|
(71.9 – 127.5)
|
(62.2 – 122.3)
|
|
Body Mass Index (kg/m2)
|
32.4 ± 1.4
|
32.7 ± 1.3
|
33 ± 1.3
|
33.3 ± 1.2
|
| |
(26 – 48)
|
(25 – 45.6)
|
(25.8 – 44.6)
|
(23.4 – 40.2)
|
|
Body Fat % (DXA)
|
46.5 ± 1.7
|
44.6 ± 1.9
|
43.7 ± 1.3
|
45.8 ± 1.6
|
| |
(35.9 – 59.9)
|
(30.7 – 52.5)
|
(34.6 – 52.2)
|
(28.8 – 55.5)
|
|
Waist Circumference (cm)
|
100.3 ± 3.6
|
103.7 ± 2.6
|
104 ± 3.2
|
102.2 ± 3.2
|
| |
(80 – 131)
|
(82 – 118)
|
(83.5 – 135.5)
|
(81.5 – 124.5)
|
|
Waist: Hip Ratio
|
0.85 ± 0.02
|
0.87 ± 0.02
|
0.88 ± 0.02
|
0.86 ± 0.02
|
| |
(0.75 – 1.01)
|
(0.76 – 1)
|
(0.78 – 1.03)
|
(0.74 – 1.02)
|
|
Fasting Triglyceride (mmol/L)
|
1.25 ± 0.17
|
1.36 ± 0.19
|
1.27 ± 0.12
|
1.1 ± 0.1
|
| |
(0.48 – 2.6)
|
(0.62 – 3.01)
|
(0.51 – 2.14)
|
(0.48 – 1.91)
|
|
Fasting Total Cholesterol (mmol/L)
|
5.51 ± 0.29
|
5.83 ± 0.32
|
5.49 ± 0.38
|
5.71 ± 0.31
|
| |
(2.59 – 7.12)
|
(3.58 – 7.87)
|
(2.92 – 8.95)
|
(3.74 – 9.2)
|
|
Fasting HDL Cholesterol (mmol/L)
|
1.42 ± 0.11
|
1.38 ± 0.09
|
1.34 ± 0.08
|
1.43 ± 0.11
|
| |
(0.9 – 2.28)
|
(0.91 – 1.99)
|
(0.91 – 2.19)
|
(0.71 – 2.08)
|
|
Fasting LDL Cholesterol (mmol/L)
|
3.51 ± 0.26
|
3.89 ± 0.3
|
3.56 ± 0.33
|
3.78 ± 0.27
|
| |
(1.42 – 5.26)
|
(2.08 – 6.06)
|
(1.58 – 7.02)
|
(2.4 – 6.88)
|
|
Fasting Glucose (mmol/L)
|
5.35 ± 0.13
|
5.68 ± 0.17
|
5.81 ± 0.46
|
5.38 ± 0.13
|
| |
(4.55 – 6.22)
|
(4.39 – 7.11)
|
(4.91 – 7.17)
|
(4.2 – 6.46)
|
|
HOMA2-IR
|
1.92 ± 0.28
|
1.72 ± 0.52
|
1.86 ± 0.18
|
1.86 ± 0.13
|
| |
(1 – 4.7)
|
(0.9 – 2.5)
|
(0.7 – 3.5)
|
(1.2 – 2.8)
|
|
NEFA (mmol/L)
|
0.51 ± 0.03
|
0.5 ± 0.04
|
0.49 ± 0.04
|
0.46 ± 0.03
|
| |
(0.3 – 0.79)
|
(0.17 – 0.87)
|
(0.18 – 0.94)
|
(0.29 – 0.7)
|
- Values are mean ± SEM and (range) for n = 64 participants at baseline. BIA: bioelectrical impedance analysis. DXA: dual-energy x-ray absorptiometry. HOMA2-IR: homeostasis model assessment of insulin resistance. NEFA: non-esterified fatty acid.
